MDMA-assisted psychotherapy (MAP) for trauma has shown impressive results, with 71% of participants no longer meeting PTSD criteria and 86% reporting significant symptom reduction.
In the most recent trial, MAP had a dropout rate of just 1.9%, significantly lower than the dropout rates of 56% and 46% seen in prolonged exposure and cognitive processing therapy.
Collection
[
|
...
]